NE Omaha의 대장직장암 임상 시험
대장직장암 관련 연구 18개가 Omaha 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Family Communications After Genetic Testing
피험자 모집 중건강한 지원자 환영
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
피험자 모집 중2상
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9마일 거리
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
피험자 모집 중관찰 연구건강한 지원자 환영
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
피험자 모집 중1상
- Exelixis Clinical Site #2, Omaha
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
피험자 모집 중1/2상
- Nebraska Cancer Specialists, Omaha
- XCancer, Omaha
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
피험자 모집 중2상
- Nebraska Cancer Specialists - Omaha - Wright Street /ID# 271646, Omaha
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
피험자 모집 중3상
- Nebraska Cancer Specialists, Omaha
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
피험자 모집 중3상
- Nebraska Cancer Specialists Midwest Cancer Center, Omaha
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
피험자 모집 중2/3상
- University Of Nebraska Medical Center, Omaha
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
피험자 모집 중1/2상
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
피험자 모집 중3상
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Methodist, Omaha
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Bergan, Omaha
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Legacy, Omaha
- 외 2개
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
피험자 모집 중1상
- Nebraska Cancer Specialists, Omaha
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
피험자 모집 중2상
- Nebraska Cancer Specialists, Omaha
Lead-212 PSV359 Therapy for Patients With Solid Tumors
피험자 모집 중1/2상
- Nebraska Cancer Specialists, Omaha
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
피험자 모집 중1상
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
- XCancer Omaha / Urology Cancer Center, Omaha
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
피험자 모집 중3상건강한 지원자 환영
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
- 외 1개
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Nebraska Cancer Specialists, Omaha
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
피험자 모집 중관찰 연구
- Nebraska Cancer Specialists, Omaha
다른 도시의 대장직장암 시험
- Houston, TX연구 102개
- New York City, NY연구 78개
- Nashville, TN연구 69개
- Boston, MA연구 63개
- Los Angeles, CA연구 59개
- Arlington, VA연구 52개
- St. Louis, MO연구 50개
- San Antonio, TX연구 46개
- Philadelphia, PA연구 44개
- Grand Rapids, MI연구 40개
- Baldwin Park, CA연구 37개
- Chicago, IL연구 34개
Omaha의 다른 연구
- 전립선암연구 27개
- 비소세포폐암연구 24개
- 유방암연구 22개
- 암 (전체)연구 18개
- 다발성 골수종연구 16개
- 난소암연구 14개
- 비호지킨 림프종연구 14개
- 췌장암연구 14개
- 전이성 암연구 13개
- 두경부 편평세포암연구 13개
- 심부전연구 13개
- 흑색종연구 12개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.